RhumbLine Advisers’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.57M | Sell |
|
|||||
|
2025
Q2 | $2.09M | Buy |
|
|||||
|
2025
Q1 | $1.64M | Buy |
|
|||||
|
2024
Q4 | $1.82M | Buy |
|
|||||
|
2024
Q3 | $1.81M | Sell |
|
|||||
|
2024
Q2 | $1.45M | Buy |
|
|||||
|
2024
Q1 | $1.38M | Buy |
|
|||||
|
2023
Q4 | $508K | Sell |
|
|||||
|
2023
Q3 | $408K | Buy |
|
|||||
|
2023
Q2 | $631K | Buy |
|
|||||
|
2023
Q1 | $568K | Buy |
|
|||||
|
2022
Q4 | $285K | Buy |
|
|||||
|
2022
Q3 | $412K | Buy |
|
|||||
|
2022
Q2 | $364K | Buy |
|
|||||
|
2022
Q1 | $439K | Buy |
|
|||||
|
2021
Q4 | $607K | Sell |
|
|||||
|
2021
Q3 | $890K | Buy |
|
|||||
|
2021
Q2 | $1.21M | Buy |
|
|||||
|
2021
Q1 | $1.37M | Sell |
|
|||||
|
2020
Q4 | $1.77M | Buy |
|
|||||
|
2020
Q3 | $538K | Sell |
|
|||||
|
2020
Q2 | $636K | Buy |
|
|||||
|
2020
Q1 | $283K | Buy |
|
|||||
|
2019
Q4 | $220K | Buy |
|
|||||
|
2019
Q3 | $155K | Buy |
|
|||||
|
2019
Q2 | $221K | Buy |
|
|||||
|
2019
Q1 | $168K | Sell |
|
|||||
|
2018
Q4 | $173K | Buy |
|
|||||
|
2018
Q3 | $199K | Sell |
|
|||||
|
2018
Q2 | $204K | Buy |
|
|||||
|
2018
Q1 | $149K | Buy |
|
|||||
|
2017
Q4 | $95K | Sell |
|
|||||
|
2017
Q3 | $184K | Buy |
|
|||||
|
2017
Q2 | $254K | Buy |
|
|||||
|
2017
Q1 | $208K | Buy |
|
|||||
|
2016
Q4 | $158K | Buy |
|
|||||
|
2016
Q3 | $91K | Buy |
|
|||||
|
2016
Q2 | $65K | Sell |
|
|||||
|
2016
Q1 | $144K | Hold |
|
|||||
|
2015
Q4 | $140K | Buy |
|
|||||
|
2015
Q3 | $165K | Buy |
|
|||||
|
2015
Q2 | $217K | Buy |
|